argus

Eris Lifesciences Limited

NSE: ERISINE406M0102417,963 Cr

Timeline

Time (IST)TypeMEventSrc
31 Aug, 11:19 amresults2Eris Lifesciences Limited announces the outcome of its Board Meeting held on August 31, 2026, which typically involves the approval of quarterly financial results.nse
06 Aug, 09:44 amEris Lifesciences Limited has informed the Exchange about Loan Agreement.nse
06 Aug, 09:38 amEris Lifesciences Ltd - 540596 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, - Availing Working Capital Term Loan From Axis Bankbse
04 Aug, 10:43 amEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
04 Aug, 10:31 amEris Lifesciences Limited has informed the Exchange about Transcriptnse
29 Jul, 06:38 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
29 Jul, 06:31 pmEris Lifesciences Limited has informed the Exchange about Link of Recordingnse
29 Jul, 01:18 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
29 Jul, 01:16 pmEris Lifesciences Limited has informed the Exchange about Investor Presentationnse
29 Jul, 01:13 pmEris Lifesciences Ltd - 540596 - Financial Results For The Quarter Ended June 30, 2026bse
29 Jul, 01:10 pmEris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.nse
29 Jul, 01:10 pmEris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board Meetingbse
23 Jul, 12:24 pmEris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Period Ended June 30, 2026bse
23 Jun, 04:13 pmEris Lifesciences Limited has informed the Exchange regarding 'corporate presentation'.nse
08 Jun, 03:59 pmEris Lifesciences Limited has informed the Exchange regarding 'payment made of theinterest to the holders of Non-convertible Debentures'.nse
08 Jun, 03:31 pmEris Lifesciences Ltd - 540596 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCDbse
28 May, 03:41 pmEris Lifesciences Ltd - 540596 - Imposition Of Fine By BSE Limited And National Stock Exchange Of India Limitedbse
28 May, 03:32 pmEris Lifesciences Limited has informed the Exchange about Action(s) taken or orders passednse
27 May, 06:14 pmEris Lifesciences Ltd - 540596 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
27 May, 02:47 pmEris Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011nse
26 May, 05:59 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
26 May, 05:55 pmEris Lifesciences Limited has informed the Exchange about Transcriptnse
20 May, 07:29 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
20 May, 07:26 pmEris Lifesciences Limited has informed the Exchange about Link of Recordingnse
20 May, 02:57 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
20 May, 02:53 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Date of payment of Dividendbse
20 May, 02:53 pmEris Lifesciences Limited has informed the Exchange about Investor Presentationnse
20 May, 02:49 pmEris Lifesciences Ltd - 540596 - Corporate Action-Board approves Dividendbse
20 May, 02:46 pmEris Lifesciences Limited has informed the Exchange that Record date for the purpose of Dividend is 29-May-2026.nse
20 May, 02:44 pmEris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
20 May, 02:43 pmEris Lifesciences Ltd - 540596 - Financial Results For The Quarter And Financial Year Ended March 31, 2026bse
20 May, 02:38 pmEris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board Meetingbse
15 May, 02:34 pmEris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration Of Financial Results And Interim Dividendbse
12 May, 07:23 pmEris Lifesciences Limited has informed the Exchange regarding 'Credit Rating of Eris Therapeutics Limited'.nse
08 May, 05:05 pmEris Lifesciences Limited has informed the Exchange about Credit Ratingnse
08 May, 05:00 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
20 Apr, 10:25 pmEris Lifesciences Limited has informed the Exchange regarding 'INSPECTION OF SWISS PARENTERALS UNITS 1 AND 2 BY HALMED, CROATIA'.nse
31 Mar, 06:24 pmEris Lifesciences Limited has informed the Exchange regarding 'closure of the transaction related to acquisition of Probiotics business of Velbiom Probiotics Private Limited'.nse
27 Mar, 04:23 pmEris Lifesciences Ltd - 540596 - Corporate Guaranteebse
20 Mar, 04:08 pmEris Lifesciences Limited has informed the Exchange regarding a press release dated March 20, 2026, "Launch of Generic Semaglutide under the Brand "Sundae" in India.".nse
20 Mar, 04:07 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Mar, 03:29 pmEris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on March 20, 2026.nse
14 Mar, 12:50 pmEris Lifesciences Limited has informed the Exchange regarding Appointment of Mr. Vineet Varma as Non- Executive Independent Director of the company w.e.f. March 14, 2026.nse
14 Mar, 12:47 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
28 Feb, 07:08 pmEris Lifesciences Ltd - 540596 - Imposition Of Fine By BSE Limited And National Stock Exchange Of India Limitedbse
28 Feb, 07:03 pmEris Lifesciences Limited has informed the Exchange about Action(s) taken or orders passednse
24 Feb, 12:14 pmEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
24 Feb, 12:09 pmEris Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India".nse
20 Feb, 05:56 pmEris Lifesciences Limited has informed the Exchange regarding 'Corporate Presentation'.nse
20 Feb, 11:50 amEris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse